Product Name: LY2484595 (Evacetrapib) |CETP inhibitor
Product Description: LY-2484595 (Evacetrapib) is a benzazepine-based, selective inhibitor of cholesteryl ester transfer protein (CETP) at an IC50 value of 5.5 nM for human recombinant CETP. Inhibition in human plasma was 3.6 nM IC50. [1] In H295R cells at concentrations up toMedchemexpress.com
Chemical Formula: C31H36F6N6O2
Molecular Weight: 638.65
‘&“CAS NO: 212141-51-0 Vatalanib
Purity: 98%
Appearance: White Crystalline
Chemical Name: Trans-4-({(5S)-5-[{[3,5-bis(trifluoromethyl)phenyl]methyl}(2-methyl-2H-tetrazol-5- yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1H-benzazepin-1-yl}methyl) cyclohexanecarboxylic acidHBV inhibitors
Solubility: Up to 22 mM in DMSO
Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage Condition: For longer shelf life, store solid powder at 4oC desiccated, or store DMSO solution at -20oC.PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/19254787
